GPC3 and hepatocellular carcinoma: In particular, a fully humanized monoclonal antibody was found to evoke antibody-dependent cell-mediated cytotoxicity when administered in both in vitro and in vivo experimental models employing GPC3 positive HCC cells [156,157].